Skip to main content
YUNU

Video Gallery

Redefining Imaging Workflows in Clinical Trials  |  Full Interview

At the Veeva R&D and Quality Summit in Boston, Moe Alsumidaie interviewed Jeff Sorenson, CEO of Yunu, and Steve Tolle, Chief Product & Technology Officer at Ignitedata, on how the updated ICH E6(R3) guidance is transforming imaging in clinical trials.

Redefining Clinical Imaging: How a Site-First Approach is Setting a New Standard for Transparency & Data Integrity | Full Interview

At DPHARM 2025, Patrick McNamara, Chief Commercial Officer at Yunu, shared how Yunu is redefining imaging in clinical research by solving site-level challenges first.

Redefining Clinical Imaging: Error Rates in Imaging Assessments | Patrick McNamara | Part 1

When large imaging centers published results before and after adopting Yunu, error rates in imaging assessments dropped from 25–50% to under 2%. That single metric flipped the narrative — from operational support tool to scientific enabler.

Redefining Clinical Imaging: Real-Time Access to Source Imaging Data|Patrick McNamara|Part 2

Yunu provides real-time access to source imaging data and helps rebuild the trust between sites and sponsors.

Redefining Clinical Imaging: Are your trials built to pass audit? |Patrick McNamara|Part 3

As Patrick McNamara shared, the center’s success came from using a fully traceable and transparent platform, where every imaging time point, every process, and every audit trail was digital and verifiable. The result? Total confidence — not just in compliance, but in data credibility.

Redefining Clinical Imaging: Bottlenecks in Imaging-Based Trials|Patrick McNamara|Part 4

The biggest bottleneck in imaging-based trials often isn’t quality — it’s capacity.And the moment you can shift work across cancer centers with a single click, the entire operations model changes.

Redefining Clinical Imaging: Delays in Imaging|Patrick McNamara|Part 5

Delays in imaging are not just operational challenges. They directly impact whether patients remain eligible for life saving trials. Hear from Yunu CCO, Patrick McNamara as he highlights why faster, connected imaging workflows are essential to protecting patient access and why the industry can no longer accept delays as normal.

Imaging as Infrastructure: Why Sponsors Must Rethink Oversight in Modern Trials | Full Interview

At DPHARM, Paul McCracken, Founder and Principal of RadiaNova Consulting, sheds light on the hidden challenges of clinical trial imaging and how radiopharmaceutical studies are transforming its role.

Imaging as Infrastructure: Interview Part 5

Paul McCracken, founder and principal of RadiaNova Consulting, speaks about metrics that reflect site performance.


Imaging as Infrastructure: Interview Part 4

What’s the right balance between innovation speed and algorithmic transparency in our field?

Imaging as Infrastructure: Interview Part 3

Are sponsors ready to treat imaging as the strategic core of radiopharmaceutical development—not an afterthought?

Imaging as Infrastructure: Interview Part 2

Paul J. McCracken, Ph.D. from RadiaNova Consulting, LLC put it bluntly: If imaging isn’t baked into your protocol design — your timing, equipment specs, and site readiness — you’re already behind.

Imaging as Infrastructure: Interview Part 1

Paul J. McCracken, Ph.D., founder of RadiaNova Consulting, LLC, pointed out one of the biggest blind spots in clinical trial imaging — and it’s not about technology.

The New Network Layer for Clinical Trial Imaging  |  Full Interview

Yunu CCO Patrick McNamara introduces trial imaging’s network layer: not a better version of central review or site imaging, but a new category that strengthens the expertise already in the room & wires around the operational friction that has slowed trials for years.

The Missing Layer In Trial Imaging

Yunu CCO Patrick McNamara introduces the network layer connecting every stakeholder in clinical trial imaging.

Faster Trials Start With Less Friction

Yunu CCO Patrick McNamara shows how a connected imaging network removes the operational friction slowing clinical trials down.

Earlier Signal, Straight From The Source

Yunu CCO Patrick McNamara explains how capturing imaging data at the source gives sponsors earlier visibility into trial performance.

The Right Patient, On The Right Trial

Yunu CCO Patrick McNamara explains why accurate site reads matter—and how network-level traceability keeps imaging data accountable.

The Clinical Trial Wish List

Every site carries burdens that slow trials down. At AACI CRI 2026, Yunu's Gordon Harris opens a forward-looking talk on eliminating pain points and rethinking how sites and sponsors collaborate.

Where Trial Site Imaging Workflow Breaks Down

Spreadsheets, sticky notes, and binders in hospital basements. At AACI CRI 2026, Yunu's Liz Correa breaks down the fragmented workflows quietly costing sites time, staff, and compliance.

Connecting the Site & Sponsor Trial Imaging Workflow​

Images in one system, measurements in another, and no way to connect them. At AACI CRI 2026, Yunu's Jeff Sorenson unpacks the traceability gap straining both sites and sponsors.

How Much Visibility Is Too Much

What happens when a sponsor can watch your trial unfold in real time? At AACI CRI 2026, Yunu's Jeff Sorenson asks sites how much oversight is helpful and how much is too much.

A Connected Network of Readers

If you're not the one doing the read, do you still have to field the query? At AACI CRI 2026, Yunu's Jeff Sorenson and Liz Correa explain how a connected reader network routes queries to the right people.

Signed, Then Shared​

Response often depends on more than imaging. At AACI CRI 2026, Yunu's Jeff Sorenson shows how in-platform PI sign-off means sponsors receive final, investigator-approved results they can act on.

Trial Level Configuration

At AACI CRI 2026, Yunu's team explains how configuring response criteria, access, and sign-off requirements by trial means that sponsors receive clean, decision-ready results instead of works in progress.

Site Reads and Central Reads, One System

Site reads or blinded central reads for registrational studies? At AACI CRI 2026, Yunu's Jeff Sorenson shows how one platform supports both randomization and adjudication, with same-day turnaround capabilities.

Skip the Integration Headache​

Getting images out of PACS and de-identified is the bane of many sites' existence. At AACI CRI 2026, Yunu's Jeff Sorenson and Liz Correa show how imaging flows in and out, without the IT lift.

​​SCOPE 2026 SESSION | Full Length Video
The Hidden Cost of Imaging Error in Oncology Trials

Why imaging error drives cost, delay, and discordance in trials.

When the Best Sites Still Get It Wrong

High-performing cancer centers still face major imaging errors.

When Pharma Makes Decisions on Flawed Imaging Data​

High-performing cancer centers still face major imaging errors.

The Workflow Maze Behind Imaging Friction

Complex protocols and disconnected systems create delays.

The Black Box Between Site & Sponsor

Where imaging workflow gaps create costly errors.

The Ten Percent Washout We Accept​

Why eligible cancer patients are lost to imaging error.

Building the Highway for Frictionless Imaging

A unified architecture for real-time trial collaboration.

Imaging Steps into GCP Oversight

End-to-end transparency is now a regulatory mandate.

Standardizing Imaging at the Site Level​

A unified architecture reduces manual work by 80 percent.

From Friction to Framework

An end-to-end imaging platform built for transparency.

Connectivity Is the Future of Trial Imaging

Standardized collaboration across sites, readers, and sponsors.

​​A Central Review Problem That Starts at the Site

By the time central review catches an error, the patient has already been treated, and the trial has already absorbed the cost. The real issue is the workflow for site reads.

​​When the Best Sites Still Get It Wrong

Dr. Gordon Harris explains why site reads are so difficult to get right. With complex protocols, insufficient training, and inconsistent tools, the issue is not effort. It is the lack of standardization across sites.

​​Why Clinical Trial Imaging Must Reach Beyond Major Cancer Centers​

To improve access and execution, imaging platforms must be scalable, deployable, and available wherever patients receive care.

​​Why Trial Imaging and Clinical Reports Keep Colliding

Clinical care typically compares with the prior scan, while trials require structured longitudinal assessment from baseline onward. With Yunu, assessments ensure the correct comparative calculations, and query rates dropped to less than 2%.

​​Why Trusted Site Reads Matter More Than Ever

Site reads could be incredibly valuable, but only if they are standardized, harmonized, and fully traceable. This clip highlights why that shift is now becoming possible.

​​Radiology Has to Be Part of the Trial Conversation​

Radiology is still too often overlooked in clinical trial planning. When sites commit to imaging requirements without involving radiology, the burden, budget, and workflow challenges surface later, where they are hardest to solve.

The Imaging Source of Truth for Transparent, Compliant, and Efficient Clinical Trials

Imaging has long been one of the most challenging parts of clinical trials. During the Innovation Showcase at Research Revolution 2025, our very own Dr. Gordon Harris shared that Yunu’s direct integration with Florence delivers imaging data into the ISF—streamlining site workflows, reducing manual effort, and giving sponsors real-time oversight.

Yunu Full City of Hope Panel
​June 2025
​

Join Yunu and City of Hope leaders for a candid discussion on the imaging challenges facing cancer centers today, and how bold strategies are reshaping oncology research, clinical workflows, and patient outcomes.



JPM 2024 - Imaging Wire Interview
​

What challenges are faced by imaging providers that want to participate in oncology clinical trials? Hear about the problems -- and solutions -- with Yunu co-founders Jeffrey Sorenson and Gordon Harris during this interview with The Imaging Wire's Brian Casey at the JP Morgan Health Care Conference and Biotech Showcase.

The Clinical Trial Imaging Accuracy Crisis

​Full Length Podcast
Tapping into the Yunuverse: Outsourcing & Resource Sharing
​
Dr. Gordon Harris
Yunu CSO & Co-Founder
Yunu Security & Compliance


​Dr. Gordon Harris
Yunu CSO & Co-Founder​
Yunu Partnerships & Outcome

Dr. Arcadia Cruz 
Associate Administrative Director, UCSD Moore's Cancer Center
Value to Patients, Cancer Centers, & the FDA

​Dr. Arcadia Cruz 
Associate Administrative Director, UCSD Moore's Cancer Center
Trial Protocol Challenges

​Group Discussion

​
Trial Imaging Errors: Impact to Patients

​Patrick Panlasigui
Clinical Research Manager, Fred Hutch Cancer Center
Trial Imaging: Types of Errors
& the Discovery Process

​Dr. Arcadia Cruz 
Associate Administrative Director, UCSD Moore's Cancer Center
Leveraging Technology to
Improve Efficiency
​
Patrick Panlasigui
Clinical Research Manager, Fred Hutch Cancer Center
Platform-Driven Protocol Collaboration

​Hailey McDaniels
Associate Director - Clinical Trials Operations, Yale Cancer Center
Outsourcing Imaging Protocol Support

​Hailey McDaniels
Yunu CEO & Co-Founder
Issues with Central Review

​Dr. Gordon Harris
Yunu CSO & Co-Founder
The Impact of Good Technology & Collaborators

​Hailey McDaniels
Yunu CEO & Co-Founder

Trial Imaging Error Rates

​Dr. Gordon Harris
Yunu CSO & Co-Founder
Cross-Site Collaboration

​Jeff Sorenson
Yunu CEO & Co-Founder
Billing Capabilities

​Group Discussion

APS Cross Checking Protocols

​
​Danielle Nacamuli
Yunu Sr. Clinical Operations Manager
Solving Trial Access & Diversity Challenges
​
​Dr. Gordon Harris
Yunu CSO & Co-Founder
Standardizing Trials Across Sites & Exporting Data to Sponsors
​
Jeff Sorenson & Dan Otap
Yunu CEO & Clinical Research Professional
Error Rates & Game-Changing Technology

​Dr. Arcadia Cruz 
Associate Administrative Director, UCSD Moore's Cancer Center
Complete Compliance & Audit Readiness

​Kira Pavlik
Associate Director - Clinical Trials Operations, Yale Cancer Center 


Collaborative Workflows & On-Demand Resources

​Jeff Sorenson 
Co-founder & CEO, Yunu


Workflow Automation

Michelle Liendo
MSHI, CCRP, PMP, Director of Clinical Research Operations & Management

Imaging Data Potential

Jeff Sorenson
Yunu CEO & Co-Founder

​
Imaging Data for
Precision Medicine
Dushyant Sahani
MD, Professor & Chairman of Radiology

​
Data, Context, & AI

Rajan Gopalakrishnan
MS, Director of Informatics & Info. Technology
​
Loss of Data Context,
Collect & Hold
Jeff Sorenson
Yunu CEO & Co-Founder

Importance of Accurate Site Data

Jeff Sorenson
Yunu CEO & Co-Founder
​
Gold Standard Compliance

Jessica Moehle
CCRP, Senior Clinical Research Administrative Director
Technology for Efficiency Gains

Dushyant Sahani
MD, Professor & Chairman of Radiology

Balancing Demand & Incorporating Technology

​Dushyant Sahani
MD, Professor & Chairman of Radiology